Automate Your Wheel Strategy on ACB
With Tiblio's Option Bot, you can configure your own wheel strategy including ACB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ACB
- Rev/Share 6.3856
- Book/Share 11.3204
- PB 0.5181
- Debt/Equity 0.1844
- CurrentRatio 4.3146
- ROIC 0.005
- MktCap 299964416.332
- FreeCF/Share -0.0531
- PFCF -105.1032
- PE 184.6791
- Debt/Assets 0.1227
- DivYield 0
- ROE 0.0028
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | ACB | TD Cowen | -- | Buy | -- | -- | Dec. 11, 2024 |
News
3 Cannabis Stocks For Investors To Secure For Future Gains
Published: June 20, 2025 by: MarijuanaStocks
Sentiment: Neutral
The current state of the cannabis sector has people feeling a type of way. To be more descriptive, those who are invested in marijuana stocks are feeling the backlash of the market. For some time, there has been a sharp decline in the overall trading for most top marijuana stocks. Now, you would think that with the sector down and showing no true signs of recovery, all is lost. That is not the case, as most companies are making money and having a positive impact.
Read More
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade)
Published: June 18, 2025 by: Seeking Alpha
Sentiment: Negative
Aurora Cannabis reported mixed Q4/FY2025 results, with higher-than-expected revenues offset by lower profitability due to a number of one-time expenses. Following substantial growth in recent quarters, medical cannabis sales were essentially flat on a quarter-over-quarter basis. On the conference call, management admitted to headwinds from recent regulatory changes in Poland. As a result, medical cannabis sales and profitability are expected to decline in Q1/FY2026.
Read More
Aurora Cannabis Inc. (ACB) Q4 2025 Earnings Call Transcript
Published: June 18, 2025 by: Seeking Alpha
Sentiment: Neutral
Aurora Cannabis Inc. (NASDAQ:ACB ) Q4 2025 Earnings Conference Call June 18, 2025 8:00 AM ET Company Participants Kevin Niland - Corporate Participant Miguel Martin - CEO & Executive Chairman Simona King - Chief Financial Officer Conference Call Participants Derek J. Lessard - TD Cowen, Research Division Frederico Yokota Choucair Gomes - ATB Capital Markets Inc., Research Division Matt Bottomley - Canaccord Genuity Corp., Research Division Pablo Ernesto Zuanic - Zuanic & Associates William Joseph Kirk - ROTH Capital Partners, LLC, Research Division Operator Greetings.
Read More
Aurora Cannabis Stock Falls as Canadian Producer Expects International Sales to Decline
Published: June 18, 2025 by: Investopedia
Sentiment: Negative
Aurora Cannabis (ACB) shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its international markets, which include the U.S.
Read More
Aurora Cannabis Inc. (ACB) Misses Q4 Earnings Estimates
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Negative
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.11 per share a year ago.
Read More
Aurora Cannabis: Poised For Its First Profitable Year
Published: June 16, 2025 by: Seeking Alpha
Sentiment: Positive
Aurora Cannabis is on track for its first profitable year, driven by a strategic pivot to high-margin medical cannabis and disciplined cost management. Strong international medical sales, improved margins, and debt elimination have led to consistent positive adjusted EBITDA and free cash flow. Aurora outperforms peers Tilray and Canopy Growth with better stock performance, lower dilution, and a clear path to profitability in FY2025.
Read More
Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22
Published: June 05, 2025 by: PRNewsWire
Sentiment: Neutral
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Adds Two New Cultivars to Popular Brand Portfolio in the Australian Market EDMONTON, AB , June 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has expanded their popular IndiMed brand with the launch of IndiMed TEMPO 22, available through the company's subsidiary, MedReleaf Australia. With the same consistent quality and reliable supply, this new 22% THC potency creates a greater range of treatment options available to prescribers.
Read More
Aurora Cannabis Stock Rises 30% YTD: Time to Buy or Sell?
Published: May 30, 2025 by: Zacks Investment Research
Sentiment: Positive
ACB's 30% YTD rally reflects Q3 strength, but flat EPS estimates and consumer weakness keep analysts cautious about long-term upside.
Read More
3 Marijuana Stocks For The Long Term Investing
Published: May 02, 2025 by: MarijuanaStocks
Sentiment: Positive
Marijuana stocks hold lots of potential for home-run investments in the future. In 2018, most pot stocks saw their first wave of the green rush. Yet over the last several years, this has not been the case and things have changed drastically. Still, the way companies are keeping up with. Market demand profits and revenue are steadily rising. However, this success has played very little in how most marijuana stocks trade.
Read More
Aurora Cannabis Announces the Completion of a Multimillion Dollar Investment and Renaming of B.C. Manufacturing Facility
Published: April 30, 2025 by: PRNewsWire
Sentiment: Neutral
NASDAQ | TSX: ACB Company's Long-Standing Investment in Operational Excellence Continues with Industry Leading Upgrades and Renaming the Facility to Aurora Alpine EDMONTON, AB , April 30, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the completion of a multi-year investment of $3 million in improvements to its manufacturing facility in Pemberton, British Columbia. These upgrades are a combination of Aurora's proprietary high-performing genetics and state-of-the-art engineering design which have resulted in optimal cultivation conditions, expanded output, and superior product quality.
Read More
Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars
Published: March 20, 2025 by: PRNewsWire
Sentiment: Neutral
NASDAQ | TSX: ACB Groundbreaking research at Aurora Coast, Aurora's world-class research and development facility, sets new standard in cannabis science EDMONTON, AB , March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in cannabis sativa. The development of this proprietary genetic marker technology, which is now in use in Aurora's breeding program, is set to produce powdery mildew resistant cultivars that will be explored …
Read More
3 Canadian Marijuana Stocks To Watch For Future Gains 2025
Published: March 19, 2025 by: MarijuanaStocks
Sentiment: Neutral
Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U.S., can greatly affect how shareholders think. Additionally, oversupply in certain regions has led to falling prices, which negatively affects revenue for companies in the sector. This has created a volatile sector where the trading behavior of the most public companies is more on the low end.
Read More
Aurora Cannabis Rides the Global Legalization Wave: Should You Invest?
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics and deep regulatory knowledge.
Read More
Are Medical Stocks Lagging Aurora Cannabis (ACB) This Year?
Published: March 17, 2025 by: Zacks Investment Research
Sentiment: Negative
Here is how Aurora Cannabis Inc. (ACB) and Concentra Group (CON) have performed compared to their sector so far this year.
Read More
High-Potential Canadian Cannabis Stocks to Watch This Month
Published: March 13, 2025 by: MarijuanaStocks
Sentiment: Positive
The Canadian cannabis sector remains a key player in the global market. Many top Canadian companies are expanding into the U.S. in anticipation of future federal legalization. The U.S. cannabis industry continues to grow rapidly, with sales expected to surpass $40 billion in 2025. More states are legalizing cannabis, increasing market opportunities for Canadian producers. Recently, lawmakers introduced new federal reform bills that could ease banking restrictions and boost industry expansion. Investors are closely watching these developments as they could impact stock performance. With growing demand and regulatory progress, top Canadian cannabis stocks remain attractive.
Read More
Top Marijuana Stocks To Know In Today's Stock Market 2025
Published: March 05, 2025 by: MarijuanaStocks
Sentiment: Positive
As the cannabis industry continues to grow, more companies are expanding their product lines beyond traditional flower sales. This includes edibles, oils, and wellness products, attracting a broader consumer base. The demand for more cannabis products is helping bridge some gaps between existing players. For example, when companies partner in some way to create and release products, it often has a positive impact all the way around for the companies.
Read More
Is Aurora Cannabis (ACB) Stock Outpacing Its Medical Peers This Year?
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Aurora Cannabis Inc. (ACB) and AdaptHealth Corp. (AHCO) have performed compared to their sector so far this year.
Read More
Wall Street Analysts Predict a 25.67% Upside in Aurora Cannabis (ACB): Here's What You Should Know
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive
The mean of analysts' price targets for Aurora Cannabis (ACB) points to a 25.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read More
Best Value Stocks to Buy for February 21st
Published: February 21, 2025 by: Zacks Investment Research
Sentiment: Positive
ACB, and PRTH made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 21, 2024.
Read More
Aurora Cannabis Skyrockets After Earnings: Should You Buy Into the Rally?
Published: February 12, 2025 by: The Motley Fool
Sentiment: Positive
The year is a more than a month old, but Aurora Cannabis (ACB -2.87%) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year began -- and that rally began only a few days ago.
Read More
Aurora Cannabis: Strong Buy On Blowout Results And Constructive Outlook
Published: February 09, 2025 by: Seeking Alpha
Sentiment: Positive
Last week, Aurora Cannabis reported blowout Q3/FY2025 results with sales, gross margins, profitability, and free cash flow reaching new all-time highs. As a leader in the medical cannabis space, the company is enjoying premium margins. Following the descheduling of cannabis in Germany last year, sales in Europe have increased substantially. Cash, restricted cash and cash equivalents increased to $180.2 million. The company's core cannabis operations remain debt free.
Read More
About Aurora Cannabis Inc. (ACB)
- IPO Date 2014-07-15
- Website https://www.auroramj.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Miguel Martin
- Employees 1073